COVID-19-Associated Mortality in US Veterans with and without SARS-CoV-2 Infection

被引:7
|
作者
Suzuki, Ayako [1 ,2 ]
Efird, Jimmy T. [3 ]
Redding, Thomas S. [3 ]
Thompson, Andrew D. Jr Jr [3 ]
Press, Ashlyn M. [3 ]
Williams, Christina D. [3 ,4 ,5 ]
Hostler, Christopher J. [6 ,7 ]
Hunt, Christine M. [1 ,2 ,3 ]
机构
[1] Duke Univ, Div Gastroenterol, Durham, NC 27710 USA
[2] Durham VA Med Ctr, Div Gastroenterol, Durham, NC 27705 USA
[3] Durham VA Hlth Care Syst, VA Cooperat Studies Program Epidemiol Ctr, Durham, NC 27705 USA
[4] Duke Univ, Dept Med, Durham, NC 27710 USA
[5] Duke Univ Hlth Care Syst, Duke Univ Sch Med, Duke Canc Inst, Durham, NC 27710 USA
[6] Duke Univ, Div Infect Dis, Sch Med, Durham, NC 27710 USA
[7] Durham VA Hlth Care Syst, Infect Dis Sect, Durham, NC 27705 USA
关键词
COVID-19; risk factor; mortality; smoking; PREVALENCE; CARE;
D O I
10.3390/ijerph18168486
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: We performed an observational Veterans Health Administration cohort analysis to assess how risk factors affect 30-day mortality in SARS-CoV-2-infected subjects relative to those uninfected. While the risk factors for coronavirus disease 2019 (COVID-19) have been extensively studied, these have been seldom compared with uninfected referents. Methods: We analyzed 341,166 White/Black male veterans tested for SARS-CoV-2 from March 1 to September 10, 2020. The relative risk of 30-day mortality was computed for age, race, ethnicity, BMI, smoking status, and alcohol use disorder in infected and uninfected subjects separately. The difference in relative risk was then evaluated between infected and uninfected subjects. All the analyses were performed considering clinical confounders. Results: In this cohort, 7% were SARS-CoV-2-positive. Age >60 and overweight/obesity were associated with a dose-related increased mortality risk among infected patients relative to those uninfected. In contrast, relative to never smoking, current smoking was associated with a decreased mortality among infected and an increased mortality in uninfected, yielding a reduced mortality risk among infected relative to uninfected. Alcohol use disorder was also associated with decreased mortality risk in infected relative to the uninfected. Conclusions: Age, BMI, smoking, and alcohol use disorder affect 30-day mortality in SARS-CoV-2-infected subjects differently from uninfected referents. Advanced age and overweight/obesity were associated with increased mortality risk among infected men, while current smoking and alcohol use disorder were associated with lower mortality risk among infected men, when compared with those uninfected.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Are Kidneys Affected by SARS-CoV-2 Infection? An Updated Review on COVID-19-Associated AKI
    Fabrizi, Fabrizio
    Nardelli, Luca
    Regalia, Anna
    Zanoni, Francesca
    Castellano, Giuseppe
    PATHOGENS, 2024, 13 (04):
  • [2] SARS-CoV-2 in the bile of a patient with COVID-19-associated gallbladder disease
    Liao, Yusheng
    Wang, Bangmao
    Wang, Jian
    Shu, Juan
    Zhou, Weilai
    Zhang, Heng
    ENDOSCOPY, 2020, 52 (12) : 1148 - 1148
  • [3] Absence of SARS-CoV-2 RNA in COVID-19-associated intestinal endothelialitis
    Klaus Stahl
    Jan Hinrich Bräsen
    Marius M. Hoeper
    Sascha David
    Intensive Care Medicine, 2021, 47 : 359 - 360
  • [4] Absence of SARS-CoV-2 RNA in COVID-19-associated intestinal endothelialitis
    Stahl, Klaus
    Braesen, Jan Hinrich
    Hoeper, Marius M.
    David, Sascha
    INTENSIVE CARE MEDICINE, 2021, 47 (03) : 359 - 360
  • [5] Endothelial SARS-CoV-2 infection is not the underlying cause of COVID-19-associated vascular pathology in mice
    Gao, Siqi
    Tang, Alan T.
    Wang, Min
    Buchholz, David W.
    Imbiakha, Brian
    Yang, Jisheng
    Chen, Xiaowen
    Hewins, Peter
    Mericko-Ishizuka, Patricia
    Leu, N. Adrian
    Sterling, Stephanie
    August, Avery
    Jurado, Kellie A.
    Morrisey, Edward E.
    Aguilar-Carreno, Hector
    Kahn, Mark L.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [6] Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation
    Janssen, Marlou T. H. F.
    Ramiro, Sofia
    Landewe, Robert B. M.
    Magro-Checa, Cesar
    Mostard, Remy L. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (10) : 1362 - 1363
  • [7] COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic
    Chandley, Pankaj
    Subba, Priyanka
    Rohatgi, Soma
    VACCINES, 2022, 10 (08)
  • [8] SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease
    Menon, Rajasree
    Otto, Edgar A.
    Sealfon, Rachel
    Nair, Viji
    Wong, Aaron K.
    Theesfeld, Chandra L.
    Chen, Xi
    Wang, Yuan
    Boppana, Avinash S.
    Luo, Jinghui
    Yang, Yingbao
    Kasson, Peter M.
    Schaub, Jennifer A.
    Berthier, Celine C.
    Eddy, Sean
    Lienczewski, Chrysta C.
    Godfrey, Bradley
    Dagenais, Susan L.
    Sohaney, Ryann
    Hartman, John
    Fermin, Damian
    Subramanian, Lalita
    Looker, Helen C.
    Harder, Jennifer L.
    Mariani, Laura H.
    Hodgin, Jeffrey B.
    Sexton, Jonathan Z.
    Wobus, Christiane E.
    Naik, Abhijit S.
    Nelson, Robert G.
    Troyanskaya, Olga G.
    Kretzler, Matthias
    KIDNEY INTERNATIONAL, 2020, 98 (06) : 1502 - 1518
  • [9] COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding
    Huang, Jhong-Ru
    Shen, Hsiao-Chin
    Sun, Chuan-Yen
    Chen, Wei-Chih
    Chen, Yuh-Min
    Feng, Jia-Yih
    Yang, Kuang-Yao
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (12) : 2617 - 2625
  • [10] Partial COVID-19 vaccination associated with reduction in postoperative mortality and SARS-CoV-2 infection
    Prasad, Nikhil K.
    Englum, Brian R.
    Mayorga-Carlin, Minerva
    Turner, Douglas J.
    Sahoo, Shalini
    Sorkin, John D.
    Lal, Brajesh K.
    AMERICAN JOURNAL OF SURGERY, 2022, 224 (04): : 1097 - 1102